-
Mashup Score: 1How Does Lecanemab Work in Alzheimer's? - 7 month(s) ago
How does lecanemab work in AD? A study suggests it blocks the action of a molecular cascade implicated in amyloidosis.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4
An abstract is unavailable.
Source: journals.lww.comCategories: Latest Headlines, NeurologyTweet-
People are talking about: #Lecanemab’s approval brings with it a range of new challenges posed by an intensive infusion regimen that must be carefully monitored with frequent advanced imaging: https://t.co/F6SSco6r4G #NeuroTwitter #dementia #Alzheimers #Leqembi @AANMember https://t.co/IOoQBNZVag
-
-
Mashup Score: 1Few Early Alzheimer's Patients Qualify for Lecanemab - 8 month(s) ago
Inclusion and exclusion criteria whittle down pool of eligible treatment candidates
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Few people with early #Alzheimers disease met eligibility criteria for the new anti-amyloid monoclonal antibody treatments #lecanemab and #aducanumab, cross-sectional data from the @MayoClinic Study of Aging showed. @MedPageNeuro @judyreports https://t.co/jgKq58KILV
-
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: Latest Headlines, NeurologyTweet-
Most read this week: Most regulatory and insurance hurdles for #lecanemab have been cleared. Now, doctors and programs caring for patients with #Alzheimers are preparing to face the challenges that come with the drug: https://t.co/F6SSco6r4G #NeuroTwitter #dementia @AANMember https://t.co/7giYiFhNaD
-
-
Mashup Score: 0
A minimalist policy for a minimalist treatment
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The #Medicare program announced it will only cover costs of #lecanemab (Leqembi) for patients who have been entered into a registry. @AlexChaitoff & Jerry Avorn, MD, argue that this requirement will be a barrier to patient access. https://t.co/TO9OapWETC https://t.co/TO9OapWETC
-
-
Mashup Score: 3Wolters Kluwer Health - 10 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
The @US_FDA has granted traditional approval to #lecanemab, an amyloid beta-directed antibody to treat adults with #Alzheimers disease: https://t.co/ELhAiIQn4M #Leqembi #dementia https://t.co/zGkVG2bNGX
-
-
Mashup Score: 0Alzheimer's Drug Wins Full FDA Approval - 10 month(s) ago
Decision expands lecanemab’s Medicare coverage
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Yesterday, #Lecanemab (Leqembi) became the first #Alzheimers treatment targeted at the disease process to win full FDA approval. https://t.co/ZT47RLQUPU
-
-
Mashup Score: 0
Screening, administration, and eligibility concerns remain
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
RT @mia_geri28: Wrote my third OpEd on @medpagetoday regarding #lecanemab and how our health systems are NOT ready. https://t.co/PFT7kSIetH
-
-
Mashup Score: 0Wolters Kluwer Health - 11 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
New #Alzheimers drug #lecanemab could raise @MedicareGov annual spending by $2 billion. And determining whether these potentially disease-modifying treatments are worth the risk—and cost—can be tough, one expert says: https://t.co/yMftjVuDJe #neurotwitter @AANMember @ROCRegional https://t.co/DvpiK6KDC1
-
-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Experts say that patients eligible for the new #Alzheimers drug #lecanemab should undergo genotyping to assess their potential risks: https://t.co/WXqmz0YuO6 #neurotwitter #dementia @AANMember @MadhavThambiset @ProfRobHoward @jasonkarlawish @JalayneArias @PittNeurology @UKSBCoA https://t.co/TgfKvRWU24
-
How does #lecanemab work in AD? A study suggests it blocks the action of a molecular cascade implicated in amyloidosis. #Alzheimers #MedTwitter https://t.co/rRGdCuUfPk